Cargando…
Molecular classification of solid tumours: towards pathway-driven therapeutics
The last decade has witnessed unprecedented developments in the genetic and epigenetic analyses of solid tumours. Transcriptional and DNA copy-number studies have improved our understanding and classification of solid tumours and highlighted the patterns of genomic aberrations associated with outcom...
Autores principales: | Swanton, C, Caldas, C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696770/ https://www.ncbi.nlm.nih.gov/pubmed/19367275 http://dx.doi.org/10.1038/sj.bjc.6605031 |
Ejemplares similares
-
Cancer heterogeneity: implications for targeted therapeutics
por: Fisher, R, et al.
Publicado: (2013) -
How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine
por: Gerlinger, M, et al.
Publicado: (2010) -
The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours
por: Thomas, S J, et al.
Publicado: (2015) -
The measurement and therapeutic implications of circulating tumour cells in breast cancer
por: Smerage, J B, et al.
Publicado: (2006) -
Solid‐Phase Protein Modifications: Towards Precision Protein Hybrids for Biological Applications
por: Kuan, Seah Ling, et al.
Publicado: (2020)